Global Aging And Emerging Markets Will Fuel Specialty And Biosimilars
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
13 Jul 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
₹2,934.00
34.4% undervalued intrinsic discount20 Aug
₹1,924.00
1Y
14.5%7D
-5.2%